These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2871399)

  • 1. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 May; 1(8490):1150-1. PubMed ID: 2871399
    [No Abstract]   [Full Text] [Related]  

  • 2. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
    [No Abstract]   [Full Text] [Related]  

  • 3. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 4. Lisuride and pergolide in Parkinson's disease.
    Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D
    Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769
    [No Abstract]   [Full Text] [Related]  

  • 5. One year treatment with lisuride delivery pump in Parkinson's disease.
    Ruggieri S; Stocchi F; Carta A; Bragoni M; Agostini C; Barbato L; Agnoli A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):173-83. PubMed ID: 2748858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
    Bittkau S; Przuntek H
    J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous dopaminergic stimulation in Parkinson disease].
    Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
    Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
    Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
    Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
    J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisuride infusion pump in Parkinson's disease. A report of two cases.
    Gershanik OS; Scipioni O; García S
    J Neural Transm Suppl; 1988; 27():85-90. PubMed ID: 2969955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
    Obeso JA; Luquin MR; Martínez-Lage JM
    Lancet; 1986 Mar; 1(8479):467-70. PubMed ID: 2869209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous lisuride infusions in Parkinson's disease.
    Critchley PH; Grandas Perez F; Quinn NP; Parkes JD; Marsden CD
    J Neural Transm Suppl; 1988; 27():55-60. PubMed ID: 2969953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
    Fernandez Pardal M; Micheli F; Gatto M; Perez y Gonzalez N
    J Neural Transm Suppl; 1988; 27():75-84. PubMed ID: 2969954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At the receiving end of the lisuride pump.
    Todes CJ
    Lancet; 1986 Jul; 2(8497):36-7. PubMed ID: 2873331
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychosis and the lisuride pump.
    Critchley P; Grandas Perez F; Quinn N; Coleman R; Parkes D; Marsden CD
    Lancet; 1986 Aug; 2(8502):349. PubMed ID: 2874361
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J; Luquin MR; Obeso JA
    Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ergot derivative lisuride in Parkinson's disease.
    Suchy I; Horowski R
    Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of lisuride after subcutaneous infusion.
    Krause W; Nieuweboer B; Ruggieri S; Stocchi F; Suchy I
    J Neural Transm Suppl; 1988; 27():71-4. PubMed ID: 3165439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisuride combined with levodopa in advanced Parkinson disease.
    Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V
    Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous lisuride infusion for Parkinson's disease.
    Obeso JA; Martinez-Lage JM; Luquin MR; Bolio N
    Ann Neurol; 1983 Aug; 14(2):252. PubMed ID: 6625541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.